Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus

NCT05846971 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Capsulomics, Inc.